Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lymphocyte Crossmatch Testing or Donor HLA-DP and -DQ Allele Typing Effectiveness in Single Cord Blood Transplantation for Patients With Anti-HLA Antibodies Other Than Against HLA-A, -B, -C, and -DRB1.
Osada M, Yamamoto H, Watanabe O, Yamaguchi K, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Takagi S, Makino S, Asano-Mori Y, Yamamoto G, Taniguchi S, Wake A, Uchida N. Osada M, et al. Among authors: asano mori y. Transplant Cell Ther. 2024 Apr 17:S2666-6367(24)00350-6. doi: 10.1016/j.jtct.2024.04.011. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38641011
Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: a matched pair comparison with tacrolimus alone.
Uchida N, Wake A, Nakano N, Ishiwata K, Takagi S, Tsuji M, Yamamoto H, Kato D, Matsuno N, Masuoka K, Araoka H, Asano-Mori Y, Izutsu K, Makino S, Yoneyama A, Taniguchi S. Uchida N, et al. Transplantation. 2011 Aug 15;92(3):366-71. doi: 10.1097/TP.0b013e318223d7ac. Transplantation. 2011. PMID: 21677598 Clinical Trial.
Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies.
Yamamoto H, Uchida N, Matsuno N, Ota H, Kageyama K, Wada S, Kaji D, Nishida A, Ishiwata K, Takagi S, Tsuji M, Asano-Mori Y, Yamamoto G, Izutsu K, Masuoka K, Wake A, Yoneyama A, Makino S, Taniguchi S. Yamamoto H, et al. Biol Blood Marrow Transplant. 2014 Oct;20(10):1634-40. doi: 10.1016/j.bbmt.2014.06.024. Epub 2014 Jun 24. Biol Blood Marrow Transplant. 2014. PMID: 24972251 Free article.
Stenotrophomonas maltophilia bloodstream infections in adult recipients of umbilical cord blood transplantation.
Kimura M, Yamamoto H, Uchida N, Ogura S, Yamamuro R, Mitsuki T, Yuasa M, Kaji D, Kageyama K, Nishida A, Taya Y, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Wake A, Taniguchi S, Araoka H. Kimura M, et al. Transplant Cell Ther. 2021 Mar;27(3):269.e1-269.e7. doi: 10.1016/j.jtct.2020.11.020. Epub 2020 Dec 17. Transplant Cell Ther. 2021. PMID: 33781536 Free article.
Successful sustained engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with severe aplastic anemia.
Yamamoto H, Kato D, Uchida N, Ishiwata K, Araoka H, Takagi S, Nakano N, Tsuji M, Asano-Mori Y, Matsuno N, Masuoka K, Izutsu K, Wake A, Yoneyama A, Makino S, Taniguchi S. Yamamoto H, et al. Blood. 2011 Mar 17;117(11):3240-2. doi: 10.1182/blood-2010-08-295832. Epub 2011 Jan 13. Blood. 2011. PMID: 21233316 Free article.
A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning.
Takagi S, Araoka H, Uchida N, Uchida Y, Kaji D, Ota H, Nishida A, Ishiwata K, Tsuji M, Yamamoto H, Ito T, Matsuno N, Yamamoto G, Asano-Mori Y, Hayashi M, Izutsu K, Masuoka K, Wake A, Makino S, Yoneyama A, Taniguchi S. Takagi S, et al. Int J Hematol. 2014;99(5):652-8. doi: 10.1007/s12185-014-1529-7. Epub 2014 Mar 25. Int J Hematol. 2014. PMID: 24664791
Relative incidences and outcomes of Clostridium difficile infection following transplantation of unrelated cord blood, unrelated bone marrow, and related peripheral blood in adult patients: a single institute study.
Hosokawa K, Takami A, Tsuji M, Araoka H, Ishiwata K, Takagi S, Yamamoto H, Asano-Mori Y, Matsuno N, Uchida N, Masuoka K, Wake A, Makino S, Yoneyama A, Nakao S, Taniguchi S. Hosokawa K, et al. Transpl Infect Dis. 2014 Jun;16(3):412-20. doi: 10.1111/tid.12224. Epub 2014 May 9. Transpl Infect Dis. 2014. PMID: 24810244
I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases.
Yamamoto H, Uchida N, Matsuno N, Kon A, Nishida A, Ota H, Ikebe T, Nakano N, Ishiwata K, Araoka H, Takagi S, Tsuji M, Asano-Mori Y, Yamamoto G, Izutsu K, Masuoka K, Wake A, Yoneyama A, Makino S, Taniguchi S. Yamamoto H, et al. Bone Marrow Transplant. 2015 Apr;50(4):607-9. doi: 10.1038/bmt.2014.316. Epub 2015 Jan 26. Bone Marrow Transplant. 2015. PMID: 25621796 No abstract available.
60 results